Literature DB >> 7635415

Decreased right heart blood volume determined by magnetic resonance imaging: evidence of central underfilling in cirrhosis.

S Møller1, L Søndergaard, J Møgelvang, O Henriksen, J H Henriksen.   

Abstract

Whether the central blood volume is reduced or expanded in cirrhosis is still under debate. Accordingly, the current study was undertaken to assess the volume of the heart cavities. Ten cirrhotic patients and matched controls had their right and left ventricular end-diastolic volumes (RVDV and LVDV), and end-systolic volumes (RVSV and LVSV) determined by magnetic resonance imaging (MRI). RVDV (122 vs. control 166 mL, P < .02), RVSV (41 vs. 80 mL, P < .02) and right atrial volume (47 vs. 64 mL, P < .05) were significantly reduced in the patients. In contrast, LVDV (134 vs. 129 mL, NS), LVSV (54 vs. 40 mL, NS), and left atrial volume (70 vs. 57 mL, P = .08) were normal or slightly increased. The right ejection fraction (68% vs. 53%, P < .05) was significantly increased, but the left ejection fraction was slightly reduced (61% vs. 69%, NS). The central and arterial blood volume (CBV), assessed as the cardiac output (CO) multiplied by the central circulation time, was significantly decreased (1.47 vs. 1.81 L, P < .05). The noncentral blood volume (4.43 vs. 3.64 L, P < .02), plasma volume (4.05 vs. 3.27 L, P < .02), and CO (7.11 vs. control 5.22 L/min, P < .01) were significantly increased in the patients. CCT (13.1 vs. 20.0 sec, P < .005) and the right ventricular transit time (0.79 vs. 1.35 sec, P < .005) were significantly reduced, but the left ventricular transit time was normal (0.91 vs. 0.88 sec, NS). Systemic vascular resistance was reduced (991 vs. 1,490 dyn.sec/cm5, P < .01).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1995        PMID: 7635415     DOI: 10.1002/hep.1840220216

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  10 in total

1.  Origins of cardiac dysfunction in cirrhosis.

Authors:  W Jiménez; V Arroyo
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 2.  Cirrhotic cardiomyopathy: a pathophysiological review of circulatory dysfunction in liver disease.

Authors:  S Møller; J H Henriksen
Journal:  Heart       Date:  2002-01       Impact factor: 5.994

Review 3.  Cirrhotic cardiomyopathy: a cardiologist's perspective.

Authors:  Natig Gassanov; Evren Caglayan; Nasser Semmo; Gero Massenkeil; Fikret Er
Journal:  World J Gastroenterol       Date:  2014-11-14       Impact factor: 5.742

4.  Sodium homeostasis with chronic sodium loading in preascitic cirrhosis.

Authors:  F Wong; P Liu; L Blendis
Journal:  Gut       Date:  2001-12       Impact factor: 23.059

Review 5.  Cardiovascular manifestation of end-stage liver disease and perioperative echocardiography for liver transplantation: anesthesiologist's view.

Authors:  Sangbin Han; Jaesik Park; Sang Hyun Hong; Chul Soo Park; Jongho Choi; Min Suk Chae
Journal:  Anesth Pain Med (Seoul)       Date:  2022-04-22

6.  Increased circulating pro-brain natriuretic peptide (proBNP) and brain natriuretic peptide (BNP) in patients with cirrhosis: relation to cardiovascular dysfunction and severity of disease.

Authors:  J H Henriksen; J P Gøtze; S Fuglsang; E Christensen; F Bendtsen; S Møller
Journal:  Gut       Date:  2003-10       Impact factor: 23.059

Review 7.  Cardiopulmonary complications in chronic liver disease.

Authors:  Soren Moller; Jens H Henriksen
Journal:  World J Gastroenterol       Date:  2006-01-28       Impact factor: 5.742

8.  Effects on gastric circulation of treatment for portal hypertension in cirrhosis.

Authors:  S Sezai; M Ito; Y Sakurai; K Kamisaka; T Abe; F Ikegami; Y Yamamoto; M Hirano
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

9.  Cardiac function in patients with early cirrhosis during maximal beta-adrenergic drive: a dobutamine stress study.

Authors:  Aleksander Krag; Flemming Bendtsen; Emilie Kristine Dahl; Andreas Kjær; Claus Leth Petersen; Søren Møller
Journal:  PLoS One       Date:  2014-10-03       Impact factor: 3.240

10.  Ultrasonographic prevalence and factors predicting left ventricular diastolic dysfunction in patients with liver cirrhosis: is there a correlation between the grade of diastolic dysfunction and the grade of liver disease?

Authors:  Vasilios Papastergiou; Lamprini Skorda; Phillipos Lisgos; Nikolaos Papakonstantinou; Tsampikos Giakoumakis; Konstantinos Ntousikos; Stylianos Karatapanis
Journal:  ScientificWorldJournal       Date:  2012-07-25
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.